C

Centre Hospitalier Universitaire de Lille | Claude Huriez Hospital - Gastroenterology Department

Research site
(Unclaimed)
Location
Rue Michel Polonowski, Lille, Nord, France

Site insights

Top conditions

Top treatments

Pembrolizumab
Vorasidenib
Tiuxetan
Indocyanine Green
AG-881
Vedolizumab
Zevalin
ANV419
Pegcetacoplan
Soliris

Parent organization

This site is a part of Centre Hospitalier Universitaire de Lille

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 33 total trials

A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).

The purpose of this study is to evaluate the efficacy and safety of ANV419 monotherapy or the combination of ANV419 with anti-PD1 antibody or with an...

Enrolling
Melanoma (Skin)
Advanced Solid Tumor
Drug: Ipilimumab
Drug: ANV419

Decathlon has developed ankleSOFT100 product which is medical device designed to reduce pain and joint instability during sport practice. The objecti...

Enrolling
Chronic Pain
Chronic Instability of Ankle Joint
Device: ankleSOFT100

Decathlon has developed kneeSOFT500 product, which is a medical device intended to be used on the knee to keep a physical activity on a regular basis...

Enrolling
Patellofemoral Pain Syndrome
Patellar Instability
Device: kneeSOFT500

Decathlon has developed the Elbow soft300 which is a medical device that must be positioned around the elbow to keep a physical activity on a regular...

Enrolling
Epicondylitis
Tendonitis Elbow
Device: Elbow SOFT 300
Other: Control group

Phase 3, multicenter, international, open-label, randomized, 2-arm trial investigating the safety and efficacy of IO102-IO103 in combination with pem...

Active, not recruiting
Unresectable Melanoma
Metastatic Melanoma
Drug: IO102-IO103
Drug: Pembrolizumab

This clinical study will test a newly developed cochlear implant known as CI622D. This experimental cochlear implant has been designed to slowly rele...

Not yet enrolling
Hearing Loss, Bilateral Sensorineural
Hearing Loss, Bilateral
Device: CI622D
Device: CI622

In this prospective, post-market, multi-site, open-label, crossover trial, women with urinary incontinence requiring the use of diapers (changes comp...

Invitation-only
Nocturnal Enuresis
Device: PureWick™ System
Device: Hollister® Female Urinary Pouch External Collection Device

The study objective is to compare water vapor thermotherapy with the REZŪM™ System to dual drug therapy for the treatment of symptomatic benign prost...

Enrolling
Benign Prostatic Hyperplasia (BPH)
Drug: alpha blocker and 5-alpha reductase inhibitor
Device: REZŪM

This study is designed to assess the efficacy and safety of datopotamab deruxtecan (Dato-DXd) in combination with pembrolizumab versus pembrolizumab...

Enrolling
Metastatic Non Small Cell Lung Cancer
Drug: Datopotamab Deruxtecan
Drug: Pembrolizumab

Trial sponsors

D
A
A
B
Boston Scientific logo
C
C
Civil Hospices of Lyon logo
Cochlear logo
Daiichi Sankyo logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems